
Glipizide
Sulfonylureas, the class glipizide belongs to, lower HbA1c by roughly 1.5 points on their own, and intensive control with sulfonylureas or insulin reduced small-vessel complications in a landmark trial. The trade-off is low blood sugar. GLP-1 and GIP medicines, alcohol, berberine, bitter melon and ginseng can add to that risk.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Adults with type 2 diabetes whose pancreas still makes insulin, usually alongside diet, exercise and often metformin, with a prescriber setting the dose
Common dosing range
Set by your prescriber. Labels start at 5 mg a day (2.5 mg for older adults or people with liver disease); label maximums are 40 mg a day for immediate release (above 15 mg split before meals) and 20 mg once daily for extended release
When to expect effects
Lowers blood sugar from the first doses; HbA1c reflects the change after about 3 months
Watch out for
Low blood sugar, which can be severe and prolonged, especially with skipped meals, alcohol, older age, kidney or liver disease, or when combined with other glucose-lowering medicines or supplements
What is it
Glipizide is a prescription tablet for type 2 diabetes from the sulfonylurea class. It comes as immediate-release tablets (once sold as Glucotrol, now generic) and extended-release tablets (Glucotrol XL and generics). It is often used together with metformin or other diabetes medicines. Its main risk is low blood sugar (hypoglycemia), which is why supplements that also lower blood sugar, alcohol and newer diabetes injections such as semaglutide and tirzepatide all matter when you take it.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
blood sugar (HbA1c) in type 2 diabetes Good Evidence | About 1.5 points lower HbA1c than placebo as monotherapy (95% CI 1.25 to 1.78); hypoglycemia risk ratio 2.41 | Adults with type 2 diabetes who still produce insulin | About 3 months for the full HbA1c effect |
small-vessel complications (eyes, kidneys) in type 2 diabetes Good Evidence | 25 percent fewer microvascular endpoints; 12 percent fewer diabetes-related endpoints overall | Adults with newly diagnosed type 2 diabetes | Years (about 10 years of follow-up) |
blood sugar (HbA1c) in type 2 diabetes
- Effect
- About 1.5 points lower HbA1c than placebo as monotherapy (95% CI 1.25 to 1.78); hypoglycemia risk ratio 2.41
- Best fit
- Adults with type 2 diabetes who still produce insulin
- Time
- About 3 months for the full HbA1c effect
small-vessel complications (eyes, kidneys) in type 2 diabetes
- Effect
- 25 percent fewer microvascular endpoints; 12 percent fewer diabetes-related endpoints overall
- Best fit
- Adults with newly diagnosed type 2 diabetes
- Time
- Years (about 10 years of follow-up)
Evidence for 2 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
blood sugar (HbA1c) in type 2 diabetes
Biomarker supportA 2013 meta-analysis of 31 double-blind trials (median 16 weeks) of sulfonylureas, the class glipizide belongs to, found that sulfonylurea monotherapy lowered HbA1c by 1.51 percentage points more than placebo. Added to other diabetes pills it lowered HbA1c by 1.62 points, and added to insulin by 0.46 points while lowering the insulin dose. Higher doses did not lower HbA1c more than lower doses, and hypoglycemia was about 2.4 times as common. These were short trials of the whole class, not of glipizide alone.
Bottom line: Lowers HbA1c substantially, at the cost of more low blood sugar episodes.
small-vessel complications (eyes, kidneys) in type 2 diabetes
Disease adjunctIn UKPDS 33, 3,867 adults (median age 54) with newly diagnosed type 2 diabetes were randomized to intensive control with a sulfonylurea (chlorpropamide, glibenclamide or glipizide) or insulin, or to diet-based conventional care, for about 10 years. HbA1c averaged 7.0 versus 7.9 percent. Intensive control lowered any diabetes-related endpoint by 12 percent, mostly through a 25 percent drop in microvascular endpoints such as needing laser treatment for the eyes. Diabetes-related death (10 percent lower) and death from any cause (6 percent lower) were not significantly different, and major lows and weight gain were more common with intensive treatment.
Bottom line: Tighter control with sulfonylureas or insulin cut small-vessel complications, mainly the need for laser eye treatment; survival was not clearly changed.
How it works
How to take it
What to track
Bottom line: Eat when you take it, carry fast sugar, and tell your prescriber about any new glucose-lowering product.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Severe low blood sugar, which can cause confusion, seizures, unconsciousness or injury and can last longer with kidney or liver disease. The label says lows are more likely with too little food, hard or long exercise, alcohol, or more than one glucose-lowering drug, and may be hard to recognize in older adults and people taking beta-blockers.
Possible increased risk of death from heart disease. The labels carry a class warning based on an older study (UGDP) in which tolbutamide, another sulfonylurea, was linked to about 2.5 times the heart death rate of diet alone. In a 2013 trial in 304 people with diabetes and heart disease, metformin led to fewer major heart events than glipizide over a median 5 years (hazard ratio 0.54), even though blood sugar control was similar.
Hemolytic anemia (breakdown of red blood cells) in people with G6PD deficiency.
Low sodium (hyponatremia, SIADH) and rare blood disorders such as low white cell or platelet counts have been reported with sulfonylureas.
Who should avoid it
- People with type 1 diabetes or diabetic ketoacidosis (label contraindication; these need insulin)
- People allergic to glipizide or, for the extended-release form, to sulfonamide derivatives
- People with G6PD deficiency (the extended-release label advises avoiding it; the immediate-release label advises caution; both point to a non-sulfonylurea alternative)
- Older, frail or malnourished adults and people with kidney or liver disease need cautious, lower dosing set by their prescriber
Pregnancy & breastfeeding
The extended-release label says decades of data have not identified a drug-related risk of major birth defects or miscarriage, but sulfonylureas cross the placenta and have caused low blood sugar in newborns, so the label says it should be discontinued at least 2 weeks before the expected delivery date, a step your prescriber plans. Poorly controlled diabetes in pregnancy is also risky. Plan pregnancy and diabetes treatment with your prescriber.
Interactions
The label lists alcohol among the things that make low blood sugar more likely, and says alcohol can either strengthen or weaken glipizide's effect. Flushing reactions to alcohol have been reported with sulfonylureas, but the label says clinical experience shows an extremely low incidence with glipizide. The Glucotrol XL patient guide says not to drink alcohol while taking it. Avoid drinking on an empty stomach and ask your doctor or pharmacist what amount, if any, is safe for you.
Berberine lowered fasting glucose and HbA1c in a meta-analysis of 28 trials, so it adds to glipizide's effect. Taken at 300 mg three times a day for 2 weeks it also reduced the activity of CYP2C9, the main enzyme that breaks down glipizide, which could raise glipizide levels; that study measured CYP2C9 with a test drug (losartan), and glipizide levels have not been measured in people taking berberine. Check with your prescriber before combining them and watch closely for lows.
Bitter melon has a modest glucose-lowering effect of its own: in a 4-week trial in newly diagnosed type 2 diabetes, 2,000 mg a day lowered fructosamine, though less than metformin. No study has tested it with glipizide itself, but in a small 7-day study in 15 people with type 2 diabetes, a bitter melon extract plus half doses of glibenclamide, another sulfonylurea, lowered blood sugar more than full doses. Combined with glipizide the effects could add up and cause low blood sugar. Talk to the clinician who manages your glipizide before using supplements, juice or concentrated forms.
The semaglutide label says using it with an insulin secretagogue such as glipizide may increase the risk of low blood sugar, including severe lows, and that lowering the glipizide dose may be necessary. That is your prescriber's decision; check your blood sugar as directed when semaglutide is started or increased.
The tirzepatide label warns that combining it with an insulin secretagogue such as glipizide may increase the risk of low blood sugar, including severe lows, and that a lower glipizide dose may be needed. Your prescriber decides; keep fast-acting sugar on hand in the first weeks.
The liraglutide label says adults taking a sulfonylurea or insulin with it may have a higher risk of low blood sugar, including severe lows, and that the sulfonylurea dose may need to be reduced. Your prescriber reviews this when liraglutide is started.
Fluconazole raised glipizide exposure by an average of 56.9 percent in volunteers, and severe low blood sugar has been reported with oral miconazole and diabetes pills. The labels say to monitor closely for lows; tell the prescriber of the antifungal that you take glipizide.
In a small study, 3 g of American ginseng lowered the blood sugar rise after a glucose drink by about 19 to 22 percent in 9 people with type 2 diabetes (and in 10 people without diabetes when taken 40 minutes before). On top of glipizide this could make lows more likely. Tell your prescriber before starting ginseng, including teas and multi-herb products, and monitor more closely at first.
In a 6-month double-blind trial in people with type 2 diabetes taking glipizide, adding chromium picolinate lowered glycated hemoglobin more than placebo (1.16% versus 0.4%). The abstract does not report low blood sugar, but glipizide can cause severe lows on its own, so tell your prescriber before adding chromium and check your blood sugar more often at first.
In 25 people taking glibenclamide (glyburide), a related sulfonylurea, cinnamon capsules lowered fasting glucose by 17.4 percent over 12 weeks, while a 60-person trial in people on metformin or a sulfonylurea found no significant benefit. No trial used glipizide itself or reported on lows, so tell your prescriber before daily cinnamon supplements and check your blood sugar more often at first.
In a 1990 study of 22 people on oral diabetes drugs (not named in the abstract, which describes no placebo group), a gymnema leaf extract lowered blood sugar enough that drug doses could be cut and 5 stopped their drug; a rat study with glimepiride, another sulfonylurea, found extra glucose lowering. Glipizide itself has not been tested, so talk to your prescriber before starting gymnema and watch for lows.
In a 12-week placebo-controlled trial in 69 people not well controlled on sulfonylureas, a fenugreek saponin extract lowered fasting and after-meal glucose and HbA1c further. The abstract does not name the sulfonylurea or report lows, so tell your prescriber before adding fenugreek and check your blood sugar more often at first.
Colesevelam lowers how much glipizide is absorbed. The label says glipizide should be taken at least 4 hours before colesevelam.
In 9 healthy volunteers, glucomannan taken with glibenclamide (glyburide), a related sulfonylurea, roughly halved blood levels of the drug over the first hours, although blood sugar right after the meal was lower, probably because the fiber also slows sugar absorption. Glipizide was not tested; take it at a different time from glucomannan (no specific gap has been tested), keep the timing steady and tell your prescriber if you start or stop it.
The labels say beta-blockers can strengthen or weaken glipizide's effect and can hide warning signs of low blood sugar such as a fast heartbeat and shaking. More frequent glucose checks may be needed; ask your prescriber.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.
Warnings (12)
+ alcohol
highAlcohol makes low blood sugar more likely with glipizide, and the extended-release label says it can either strengthen or weaken glipizide's glucose-lowering effect; in 10 healthy volunteers, alcohol prolonged the fall in blood sugar caused by glipizide. Flushing (disulfiram-like) reactions to alcohol have been reported with sulfonylureas, but the label says clinical experience shows an extremely low incidence with glipizide. The main risk is prolonged hypoglycemia.
+ berberine
highBerberine lowers blood sugar on its own. In a study in healthy men, two weeks of berberine (300 mg three times a day) also reduced the activity of CYP2C9, the liver enzyme that mainly breaks down glipizide; this was measured with a test drug (losartan), and glipizide levels have not been measured in people taking berberine. Taken together, the two effects can stack and increase the risk of low blood sugar (hypoglycemia), which with a sulfonylurea like glipizide can be prolonged. Do not combine them without prescriber supervision.
+ bitter melon
highBitter melon (Momordica charantia) has its own blood-sugar-lowering activity. No study has tested it with glipizide itself, but in a small 7-day study in people with type 2 diabetes, a bitter melon extract plus half doses of glibenclamide, another sulfonylurea, lowered blood sugar more than full doses of the medicine. Combined with glipizide, the effects can add together and push blood sugar too low, with the greatest risk after meals and in higher-risk patients.
+ liraglutide
highLiraglutide lowers blood sugar, but on its own it rarely causes a dangerous low because it only prompts insulin release when blood sugar is already raised. a sulfonylurea such as glipizide does not work that way; it drives insulin regardless of the current level. Combined, the glucose-lowering adds up and blood sugar can fall too far, and eating less on Liraglutide removes the buffer that would normally protect against it. Every FDA label in this class carries the same instruction.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I take berberine with glipizide?⌄
Only with your prescriber's agreement. Berberine lowers blood sugar on its own, and in a 2-week study it reduced the activity of CYP2C9, the main enzyme that breaks down glipizide. Both effects point toward a higher risk of low blood sugar.
Is it safe to drink alcohol on glipizide?⌄
Alcohol makes low blood sugar more likely, especially on an empty stomach. The label lists alcohol as a risk factor for hypoglycemia. Ask your doctor or pharmacist what is safe for you, and never drink instead of eating.
What happens if I start Ozempic, Mounjaro or another GLP-1 medicine while on glipizide?⌄
The labels for these medicines say combining them with a sulfonylurea such as glipizide raises the risk of low blood sugar, including severe lows, and that the glipizide dose may need to be lowered. Make sure the prescriber starting the GLP-1 medicine knows you take glipizide.
Do herbal blood sugar supplements like bitter melon or ginseng matter?⌄
They can. Both lowered blood sugar in small human studies, so on top of glipizide they could push it too low. Tell your prescriber before starting one, check your blood sugar more often at first, and keep fast-acting sugar with you.
Should I take glipizide before or after eating?⌄
The immediate-release label says about 30 minutes before a meal; extended-release tablets are taken with breakfast or the first main meal. The key point is not to take a dose and then skip the meal, because that is a common cause of lows.
References by claim
blood sugar (HbA1c) in type 2 diabetes
Hirst et al., 2013 · PMC (2013) link
small-vessel complications (eyes, kidneys) in type 2 diabetes
PMID 9742976 · PubMed (1998) link
Safety
Interaction: Berberine
Interaction: Bitter melon
Interaction: Ginseng (especially American ginseng)
Vuksan et al., 2000 · PubMed (2000) link
Interaction: Chromium (chromium picolinate, multivitamins and blood sugar blends with chromium)
Martin et al., 2006 · PubMed (2006) link
Interaction: Cinnamon supplements
Interaction: Gymnema (Gymnema sylvestre, gurmar)
Interaction: Fenugreek (seeds, extracts, lactation and testosterone blends)
Lu et al., 2008 · PubMed (2008) link
Interaction: Semaglutide (Ozempic, Wegovy, Rybelsus)
Ozempic (semaglutide) injection prescribing information · DailyMed (FDA label) link
Interaction: Tirzepatide (Mounjaro, Zepbound)
Mounjaro (tirzepatide) prescribing information · DailyMed (FDA label) link
Interaction: Liraglutide (Victoza, Saxenda)
Victoza (liraglutide) prescribing information · DailyMed (FDA label) link
Track Glipizide with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
